Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Anticancer Research

• Publication date

  1999-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10628337
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective killing of CD8+ cells with a `memory' phenotype (CD62Llo) by the N-acetyl-D-galactosamine-specific lectin from Viscum album L

  1998cited by this paper
• Induction of apoptosis by the N-acetyl-galactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations.

  1998cited by this paper
• Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl‐2

  1997cited by this paper
• Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumour patients

  1996cited by this paper
• Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.

  1996cited by this paper
• Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay.

  1996cited by this paper
• Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia.

  1996cited by this paper
• Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes.

  1996cited by this paper
• Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.

  1996cited by this paper
• Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.

  1996cited by this paper
• A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells.

  1995cited by this paper
• Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferation.

  1995cited by this paper
• Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells.

  1994cited by this paper
• Interleukin-6 production in B-cell neoplasias and Castleman's disease: Evidence for an additional paracrine loop

  1994cited by this paper
• Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.

  1993cited by this paper
• In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis).

  1993cited by this paper
• Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta.

  1993cited by this paper
• Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA.

  1992cited by this paper
• B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL.

  1991cited by this paper
• Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract.

  1990cited by this paper

• MicroRNA-145 attenuates IL-6-induced enhancements of sensitivity to UVB irradiation by suppressing MyD88 in HaCaT cells

  2018cites this paper
• Bone Marrow Dendritic Cells Tumor Exosomes Inhibit Differentiation of

  2013cites this paper
• Active Toll-like receptor-7 triggering of chronic lymphocytic leukemia B-cells by imiquimod

  2012cites this paper
• Tumorwachstumsstimulation durch Mistelpräparate? Fakten und Artefakte

  2008cites this paper
• Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A

  2007cites this paper
• In vitro response of stimulated B-CLL lymphocytes of patients treated with Viscum album L. extracts.

  2007cites this paper
• Tumor Exosomes Inhibit Differentiation of Bone Marrow Dendritic Cells1

  2007cites this paper
• Kanser Tedavisinde Kullanılan Ökse Otu (Viscum Album) Ekstraktının Apoptozis Mekanizması

  2007cites this paper
• Kanser Tedavisinde Kullanilan Ökse Otu (Viscum Album) Ekstraktinin Apoptozis Mekanizmasi APOPTOTIC MECHANISM OF MISTLETOE (VISCUM ALBUM) EXTRACT USED IN THE TREATMENT OF CANCER: REVIEW

  2007cites this paper
• Cytokines and Soluble Molecules in CLL

  2004cites this paper
• [Lectin compared to mistletoe use: experimental therapy form with preclinically verified risk potential].

  2002cites this paper
• Lektinbezogene Mistelanwendung: experimentelle Therapieform mit präklinisch belegtem Risikopotenzial - Erwiderung

  2002cites this paper
• Biologically active compounds from European mistletoe (Viscum album L.)1

  2002cites this paper
• Inflammatory cytokines and cytokine gene polymorphisms in chronic lymphocytic leukaemia, in primary Sjögren's syndrome and in healthy subjects

  2002cites this paper
• Application of standardized mistletoe extracts augment immune response and down regulates metastatic organ colonization in murine models.

  2001cites this paper
• Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes.

  2001cites this paper
• Dysregulative lymphoma theory revisited; what can we learn from cytokines, CD classes and genes?

  2001cites this paper
• [Mistletoe extracts in the therapy of malignant, hematological and lymphatic diseases--a monocentric, retrospective analysis over 16 years].

  2000cites this paper
• SchluÈ sselwoÈ rter

  year unknowncites this paper